Joint Commission

The Joint Commission was a nonprofit health-care and hospital accreditation body that approved mandatory standards for pain assessment and treatment in 1999. In Dopesick, its decision marks the formal arrival of pain as a central institutional concern—and a moment when the aims of better pain care could be joined to commercial promotion of opioids.

Accreditation and Pain Standards

The standards followed a broader shift toward treating pain as the “fifth vital sign,” alongside blood pressure, heart rate, respiratory rate, and temperature. OxyContin had been introduced in 1996, as doctors, hospitals, and accreditation bodies were adopting this framework. The Joint Commission took it further in 1999 by making pain-assessment and treatment standards mandatory for accredited institutions.

That change unfolded amid growing attention to patients’ experiences. Patients were rating care through formal surveys, with Press Ganey the largest survey provider, while doctors and hospitals competed for higher scores. The book describes the resulting incentive: clinicians could feel pressure to treat pain more liberally or risk losing reimbursements. The standards thus belonged to a larger system in which pain care was becoming measurable, reportable, and consequential for institutions.

Purdue Pharma’s Commercial Opportunity

Purdue Pharma recognized that hospitals would need to respond to the Joint Commission’s requirements. In a budget plan the following year, company executives described an opportunity to offer “value-added services” as pain experts and to help hospitals meet the standards with pain-assessment and management materials. The account presents this as Purdue’s commercial strategy, not as evidence that the Joint Commission endorsed OxyContin or partnered with the company.

The planned materials made the strategy concrete: Purdue budgeted $300,000 for OxyContin-branded scroll pens, $225,000 for OxyContin resource binders, and $290,000 for “Pain: The Fifth Vital Sign” wall charts and clipboards. The company envisioned its branding entering hospital routines through objects used by nurses and doctors, including lanyards for their name badges. A requirement intended to institutionalize attention to pain therefore also created an opening for a drug company to place its product identity alongside that clinical priority.

Measurement and Unintended Effects

The book distinguishes the need to address undertreated pain from confidence that pain could be reliably quantified. Pain scales made standard procedures easier to implement, but the score depended on a patient’s subjective report: experiences as different as transition labor and a stubbed toe could each be rated ten. Experts later acknowledged that such measurement was objective only in appearance. The account also notes that reliance on pain scales did not correlate with improved patient outcomes and had the effect of increasing opioid prescribing and abuse.

The standards are presented as one element in this wider transformation, not as the sole cause of expanded prescribing. Clinicians were being urged to prioritize pain at the same time that Purdue promoted OxyContin for conditions beyond cancer and advertised addiction risk as low. The Joint Commission’s standards gave institutional force to pain assessment; the unresolved question was how to translate that mandate into effective care without allowing a score, a reimbursement incentive, or a branded intervention to stand in for evidence of better outcomes.

Significance in the Book

The Joint Commission’s role is consequential because accreditation translated a changing medical ideal into mandatory hospital practice. That formal authority helped make pain visible within routine care, but the book also shows how easily a well-intentioned standard could be absorbed into systems of measurement, financial incentives, and pharmaceutical marketing. Its account does not deny the historical problem of undertreated pain; it examines the gap between recognizing that problem and knowing what treatment would actually help.